China's President Xi Jinping Pulled Plug on Jack Ma's Ant IPO
Senior government leaders were furious about the wealthy entrepreneur's criticisms of regulators in an Oct. 24 speech. The rebuke was the culmination of years of tense relations between China's most celebrated entrepreneur and a government uneasy about his influence.
Tencent Pledges Cooperation Amid Chinese Scrutiny
Tencent, the world's biggest videogame company by revenue, said its profit in the September quarter soared 89% to 38.54 billion yuan, equivalent to $5.81 billion, from the same period last year.
Revlon Reaches Deal to Avoid Bankruptcy
The cosmetics company said it has obtained adequate support from bondholders to avert a bankruptcy filing.
Cellnex to Buy CK Hutchison's European Tower Businesses in $11.8B Deal
Cellnex Telecom said that it has reached an agreement to acquire CK Hutchison's European tower businesses and assets for an initial investment of about 10 billion euros.
The Covid Vaccine News Is Great-but You Just Issued Dirt-Cheap Stock
Pfizer's coronavirus vaccine results have made the price of Rolls-Royce's rights issue appear very low in retrospect.
Boeing Forecasts Strong China Demand
Boeing Co. on Thursday released strong forecasts for China's aircraft demand, even as the aerospace company said it expects a weaker global market amid the coronavirus pandemic.
Nissan Is an Unlikely Pandemic Winner
The pandemic has been surprisingly helpful to the turnarounds underway at Nissan and its French alliance partner Renault.
Siemens Profit Beats Expectations
Siemens' industrial profit margin for the fourth quarter came in at 18.7%, while its net profit topped forecasts at EUR1.76 billion, as the engineer
Generali Posts Operating Profit Rise
Generali posted a 2.3% rise in 9-month operating profit, as a strong performance in its asset-management business and property and casualty operations offset a decline in the life segment, but its net profit fell 40% on impairments.
Scanwell Aims to Offer Instant At-Home Covid Antibody Test
Startup seeks FDA approval for an antibody test which it hopes will allow people to easily stay abreast of their immunity. The company is also readying an at-home antigen test as well as one for chronic kidney disease.
(END) Dow Jones Newswires